Page last updated: 2024-11-03

prazosin and Metastase

prazosin has been researched along with Metastase in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lamkin, DM1
Sung, HY1
Yang, GS1
David, JM1
Ma, JC1
Cole, SW1
Sloan, EK1

Other Studies

1 other study available for prazosin and Metastase

ArticleYear
α2-Adrenergic blockade mimics the enhancing effect of chronic stress on breast cancer progression.
    Psychoneuroendocrinology, 2015, Volume: 51

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Benzofura

2015